O’Shea PM, Griffin TP, Fitzgibbon M. Hypertension: the role of biochemistry in the diagnosis and management. Clin Chim Acta Int J Clin Chem. 2017;465:131–43.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318–27.
Kubozono T, Ohishi M. Prognostic significance of regional arterial stiffness for stroke in hypertension. Pulse Basel Switz. 2015;3:98–105.
Vallée A, Cinaud A, Protogerou A, Zhang Y, Topouchian J, Safar ME, et al. Arterial stiffness and coronary ischemia: new aspects and paradigms. Curr Hypertens Rep. 2020;22:5.
Humphrey JD, Harrison DG, Figueroa CA, Lacolley P, Laurent S. Central artery stiffness in hypertension and aging: a problem with cause and consequence. Circ Res. 2016;118:379–81.
CAS PubMed PubMed Central Article Google Scholar
Palombo C, Kozakova M. Arterial stiffness, atherosclerosis and cardiovascular risk: pathophysiologic mechanisms and emerging clinical indications. Vascul Pharmacol. 2016;77:1–7.
CAS PubMed Article Google Scholar
Vallée A, Lévy BL, Blacher J. Interplay between the renin-angiotensin system, the canonical WNT/β-catenin pathway and PPARγ in hypertension. Curr Hypertens Rep. 2018;20:62.
PubMed Article CAS Google Scholar
Cai T, Sun D, Duan Y, Wen P, Dai C, Yang J, et al. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res. 2016;345:206–17.
CAS PubMed Article Google Scholar
Ma S, Yao S, Tian H, Jiao P, Yang N, Zhu P, et al. Pigment epithelium-derived factor alleviates endothelial injury by inhibiting Wnt/β-catenin pathway. Lipids Health Dis. 2017;16:31.
PubMed PubMed Central Article CAS Google Scholar
Anderson TJ. Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Can J Cardiol. 2006;22(Suppl B):72B-80B.
PubMed PubMed Central Article Google Scholar
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–605.
• Catalano M, Scandale G, Carzaniga G, Cinquini M, Minola M, Dimitrov G, et al. Increased aortic stiffness and related factors in patients with peripheral arterial disease. J Clin Hypertens Greenwich Conn. 2013;15:712–6.
Janić M, Lunder M, Sabovič M. Arterial stiffness and cardiovascular therapy. BioMed Res Int. 2014;2014:621437.
PubMed PubMed Central Article CAS Google Scholar
Mozos I, Luca CT. Crosstalk between oxidative and nitrosative stress and arterial stiffness. Curr Vasc Pharmacol. 2017;15:446–56.
CAS PubMed Article Google Scholar
Ismaeel A, Brumberg RS, Kirk JS, Papoutsi E, Farmer PJ, Bohannon WT, et al. Oxidative Stress and arterial dysfunction in peripheral artery disease. Antioxid Basel Switz. 2018;7:E145.
Zanoli L, Rastelli S, Inserra G, Castellino P. Arterial structure and function in inflammatory bowel disease. World J Gastroenterol. 2015;21:11304–11.
CAS PubMed PubMed Central Article Google Scholar
Kals J, Kampus P, Kals M, Pulges A, Teesalu R, Zilmer K, et al. Inflammation and oxidative stress are associated differently with endothelial function and arterial stiffness in healthy subjects and in patients with atherosclerosis. Scand J Clin Lab Invest. 2008;68:594–601.
CAS PubMed Article Google Scholar
Zagura M, Kals J, Kilk K, Serg M, Kampus P, Eha J, et al. Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease. Hypertens Res Off J Jpn Soc Hypertens. 2015;38:840–6.
•• Loh KM, van Amerongen R, Nusse R. Generating cellular diversity and spatial form: Wnt signaling and the evolution of multicellular animals. Dev Cell. 2016;38:643–55.
CAS PubMed Article Google Scholar
Oren O, Smith BD. Eliminating cancer stem cells by targeting embryonic signaling pathways. Stem Cell Rev. 2017;13:17–23.
Al-Harthi L. Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders. J Neuroimmune Pharmacol. 2012;7:725–30.
PubMed PubMed Central Article Google Scholar
Marchetti B, Pluchino S. Wnt your brain be inflamed? Yes, it Wnt! Trends Mol Med. 2013;19:144–56.
CAS PubMed PubMed Central Article Google Scholar
Vallée A, Vallée J-N, Lecarpentier Y. Metabolic reprogramming in atherosclerosis: opposed interplay between the canonical WNT/β-catenin pathway and PPARγ. J Mol Cell Cardiol. 2019;133:36–46.
PubMed Article CAS Google Scholar
Lecarpentier Y, Schussler O, Hébert J-L, Vallée A. Molecular mechanisms underlying the circadian rhythm of blood pressure in normotensive subjects. Curr Hypertens Rep. 2020;22:50.
CAS PubMed PubMed Central Article Google Scholar
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281:1509–12.
CAS PubMed Article Google Scholar
Shtutman M, Zhurinsky J, Simcha I, Albanese C, D’Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A. 1999;96:5522–7.
CAS PubMed PubMed Central Article Google Scholar
Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol [Internet]. 2009 [cited 2017 Apr 7]; Available from: http://www.nature.com/doifinder/10.1038/nrm2717.
Sharma C, Pradeep A, Wong L, Rana A, Rana B. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway. J Biol Chem. 2004;279:35583–94.
CAS PubMed Article Google Scholar
Rosi MC, Luccarini I, Grossi C, Fiorentini A, Spillantini MG, Prisco A, et al. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J Neurochem. 2010;112:1539–51.
CAS PubMed Article Google Scholar
Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149:1192–205.
CAS PubMed Article Google Scholar
Inestrosa NC, Montecinos-Oliva C, Fuenzalida M. Wnt signaling: role in Alzheimer disease and schizophrenia. J Neuroimmune Pharmacol Off J Soc NeuroImmune Pharmacol. 2012;7:788–807.
Vallée A, Lecarpentier Y, Guillevin R, Vallée J-N. Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis. Oncotarget. 2017;8:90579–604.
PubMed PubMed Central Article Google Scholar
Vallée A, Lecarpentier Y, Vallée J-N. Hypothesis of opposite interplay between the canonical WNT/beta-catenin pathway and PPAR gamma in primary central nervous system lymphomas. Curr Issues Mol Biol. 2019;31:1–20.
Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-catenin is a target for the ubiquitin–proteasome pathway. EMBO J. 1997;16:3797–804.
CAS PubMed PubMed Central Article Google Scholar
Wu D, Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci. 2010;35:161–8.
CAS PubMed Article Google Scholar
Hur E-M, Zhou F-Q. GSK3 signalling in neural development. Nat Rev Neurosci. 2010;11:539–51.
CAS PubMed PubMed Central Article Google Scholar
Ambacher KK, Pitzul KB, Karajgikar M, Hamilton A, Ferguson SS, Cregan SP. The JNK- and AKT/GSK3β-signaling pathways converge to regulate puma induction and neuronal apoptosis induced by trophic factor deprivation. Hetman M, editor. PLoS ONE. 2012;7:e46885.
van de Schans VAM, Smits JFM, Blankesteijn WM. The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe? Eur J Pharmacol. 2008;585:338–45.
PubMed Article CAS Google Scholar
Tian Y, Cohen ED, Morrisey EE. The importance of Wnt signaling in cardiovascular development. Pediatr Cardiol. 2010;31:342–8.
Shao J-S, Aly ZA, Lai C-F, Cheng S-L, Cai J, Huang E, et al. Vascular Bmp Msx2 Wnt signaling and oxidative stress in arterial calcification. Ann N Y Acad Sci. 2007;1117:40–50.
CAS PubMed Article Google Scholar
Al-Aly Z. Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy. Transl Res J Lab Clin Med. 2008;151:233–9.
Tsaousi A, Mill C, George SJ. The Wnt pathways in vascular disease: lessons from vascular development. Curr Opin Lipidol. 2011;22:350–7.
留言 (0)